SCANDURRA, GIUSEPPA
 Distribuzione geografica
Continente #
EU - Europa 89
AS - Asia 61
NA - Nord America 60
AF - Africa 1
Totale 211
Nazione #
US - Stati Uniti d'America 59
IE - Irlanda 42
SG - Singapore 40
HK - Hong Kong 18
IT - Italia 16
DE - Germania 10
FI - Finlandia 6
AT - Austria 3
FR - Francia 3
GB - Regno Unito 3
CN - Cina 2
CZ - Repubblica Ceca 2
CA - Canada 1
CH - Svizzera 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
RO - Romania 1
TR - Turchia 1
Totale 211
Città #
Dublin 42
Singapore 27
Boardman 26
Hong Kong 18
Santa Clara 15
Agrigento 5
Helsinki 5
Palermo 5
Los Angeles 4
London 3
Brno 2
Munich 2
Tremestieri Etneo 2
Anshan 1
Buffalo 1
Falkenstein 1
Hyvinkää 1
Luxembourg 1
Milan 1
New Haven 1
Nuremberg 1
Ottawa 1
Riga 1
Rome 1
Seattle 1
Zurich 1
Totale 169
Nome #
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 36
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 23
Syringoid eccrine carcinoma of the vulva: differential diagnosis, treatment, and follow-up 17
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy 17
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 16
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 15
Pomegranate: A promising avenue against the most common chronic diseases and their associated risk factors (Review) 14
Synergistic Immune-Mediated Anti-tumour Effect of Dostarlimab and Radiotherapy in the Management of MSI-H/dMMR Endometrial Cancer: A Case Report 13
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 13
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 8
New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful? 8
Unveiling the Intricate Dance: How Cancer Orchestrates Muscle Wasting and Sarcopenia 7
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 7
The Impact of Neoadjuvant Chemotherapy on Axillary Surgical Management of Patients With Breast Cancer and Positive Axillary Lymph Nodes 6
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 5
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? 4
Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications 4
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 4
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 4
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 4
Appropriate Management of Cutaneous Adverse Events Maximizes Compliance with Sorafenib Treatment: A Single-Center Experience 2
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial 2
Eribulin mesylate use as third-line therapy in patients with metastatic breast cancer (VESPRY): a prospective, multicentre, observational study. 2
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status 2
Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 2
Correction: Mediterranean diet and quality of life in women treated for breast cancer: A baseline analysis of DEDiCa multicentre trial 2
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study 2
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 2
Sharing real-world experiences to optimize the management of olaparib toxicities: a practical guidance from an Italian expert panel 2
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice 2
The importance of planning a correct therapeutic strategy in patients with recurrent ovarian cancer. 2
Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis 2
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience 2
Multidisciplinary team for elucidation of any new mutation and how this approach can be useful to individualize any genetic result: the case of BRCA2 c.631G>A/c.7008-2A>T genotype 2
Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy 2
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study 2
De-escalation of complexity in oncoplastic breast surgery: Case series from a specialized breast center 2
Brain metastases in patients with non-small cell lung cancer: focus on the role of chemotherapy 1
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention 1
Epidermal growth factor receptor exon 20 p.S768I mutation in non-small cell lung carcinoma: A case report combined with a review of the literature and investigation of clinical significance 1
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 1
Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity 1
European e-Delphi process to define expert consensus on electrochemotherapy treatment indications, procedural aspects, and quality indicators in melanoma 1
A Survey on Knowledge and Attitudes Towards Vaccination Against Herpes Zoster Virus Among Medical Oncologists for Patients with Solid Tumors 1
Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study 1
Immune checkpoint inhibitor therapy‑related pneumonitis: How, when and why to diagnose and manage (Review) 1
Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen 1
Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 1
Totale 270
Categoria #
all - tutte 1.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202473 0 0 4 2 3 3 6 8 6 7 11 23
2024/2025197 27 12 23 9 50 76 0 0 0 0 0 0
Totale 270